Daily non-political popular news in brief.

Harnessing the power of the immune system to fight cancer

07-03-2007 · EurekAlert!

Teaching a body's own immune system to seek out and destroy cancerous tumors represents a promising way to fight a disease that kills more than 70,000 Canadians a year.

Keywords: harnessing, power, immune, system, fight, cancer

« Previous | Next »

Similar news on "Harnessing the power of the immune system to fight cancer":

A chemotherapy drug packs a one-two punch
02-20-2007 · EurekAlert!
How cancer cells are killed could turn out to be an important element in activating a patient's immune system. A new study shows that one chemotherapy drug may kill tumor cells in such a way that the immune system can recognize the cancerous cells and help fight the disease more effectively.
Similar news · Read more »
T for two: Scientists show how immune system chooses best way to fight infection
11-14-2006 · EurekAlert!
A new study has suggested a novel way of combating diseases related to the immune system, including cancer and autoimmune diseases such as type I diabetes and arthritis. The study, funded by the Wellcome Trust, appears online in the journal Nature.
Similar news · Read more »
Tiny Tampa Bay Fish Key To Evolution Of Immune System
10-05-2006 · ScienceDaily
A tiny fish offers insight into the human immune system, according to Florida researchers. The finding could lead to improved biodefense and better immune-boosting drugs to fight cancer and other disorders.
Similar news · Read more »
Common molecule notifies immune system of prostate cancer
01-10-2008 · EurekAlert!
In experiments with mice, researchers have found that the body's immune system can use a surprisingly common molecule to recognize prostate tumors. Understanding how this protein signals the immune system to respond to malignant cells may help researchers refine immunotherapy strategies that harness the body's own immune system to fight tumors.
Similar news · Read more »
Promising treatment target found in Hodgkin lymphoma
07-30-2007 · EurekAlert!
Dana-Farber Cancer Institute scientists have identified a protein that prevents the body's immune system from recognizing and attacking Hodgkin lymphoma cells. Based on this finding, the researchers are now investigating targeted therapies to disable this molecular "bodyguard" and boost a patient's ability to fight the blood cancer.
Similar news · Read more »
Melanoma drug revs immune cells but cancer cells ignore it
09-01-2007 · EurekAlert!
A new study shows that an important drug used in the treatment of malignant melanoma has little effect on the melanoma cells themselves. Instead, it activates immune-system cells to fight the disease. The drug, called interferon alpha, is used to clean up microscopic tumor cells that may remain in the body following surgery for the disease. It is the only drug approved for this purpose.
Similar news · Read more »
Jefferson researchers boost immune 'killer cells,' increase antibody effectiveness against cancer
04-18-2007 · EurekAlert!
Researchers have devised a novel method to expand the number of immune system "natural killer (NK)" cells from blood cells outside the body. They have shown in laboratory studies that adding such cells to anti-cancer therapies involving monoclonal antibody drugs such as Herceptin, which targets the HER2/neu protein on breast cancer cells, is more effective in killing cancer cells, and perhaps someday may improve treatments.
Similar news · Read more »
Study shows big power of small RNAs, not just proteins, in halting cancer
06-06-2007 · EurekAlert!
CSHL researchers have identified a family of micro RNAs that enable a known tumor suppressor network to fight cancer growth.
Similar news · Read more »
MIT model could predict cells' response to drugs
07-30-2007 · EurekAlert!
MIT researchers have developed a model that could predict how cells will respond to targeted drug therapies. Models based on this approach could help doctors make better treatment choices and drug developers identify the ideal compound. In addition, the model could help test the effectiveness of drugs for a wide range of diseases, including cancer, arthirtis, and immune system disorders.
Similar news · Read more »
Vaccine improves event-free survival for leukemia patients
12-09-2007 · EurekAlert!
Patients whose immune system responded to a peptide vaccine for leukemia enjoyed a median remission that was more than three times longer than nonresponders, a team led by researchers at the University of Texas M. D. Anderson Cancer Center reports at the 49th Annual Meeting of the American Society of Hematology.
Similar news · Read more »